UNICREDIT BANK/PUT/ELI LILLY & CO/400/0.1/18.12.24 | Market Closed - BOERSE MUENCHEN 01:10:28 27/06/2024 am IST | ||
| 0.012 EUR | +20.00% |
|
| Current month | -73.33% | ||
| 1 month | -80.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 0.012 | +20.00% |
| 25/24/25 | 0.01 | -9.09% |
| 24/24/24 | 0.011 | -8.33% |
| 21/24/21 | 0.012 | -36.84% |
| 20/24/20 | 0.019 | +1,800.00% |
Real-time BOERSE MUENCHEN
Last update June 27, 2024 at 01:10 am IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
UniCredit
|
| WKN | HC3L83 |
| ISIN | DE000HC3L837 |
| Date issued | 27/01/2023 |
| Strike | 400 $ |
| Maturity | 18/12/2024 (175 Days) |
| Parity | 10 : 1 |
| Emission price | 7.17 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9 € |
|---|---|
| Lowest since issue | 0.001 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
901.3
USD
Average target price
860.5
USD
Spread / Average Target
-4.52%
- Stock Market
- Warrants
- Warrant
